Skip to main content
Equibles

June Lee

Board Member

Eledon Pharmaceuticals, Inc. (ELDN)

Board Member

Tenaya Therapeutics, Inc. (TNYA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Eledon Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELDN alerts

About June Lee

June Lee is recorded as Board Member at Eledon Pharmaceuticals, Inc. (ELDN) and Board Member at Tenaya Therapeutics, Inc. (TNYA) since January 1, 2021. The newest filing on record that lists June Lee as Board Member at Eledon Pharmaceuticals, Inc. (ELDN) is dated April 30, 2026. The newest filing on record that lists June Lee as Board Member at Tenaya Therapeutics, Inc. (TNYA) is dated April 16, 2026. Eledon Pharmaceuticals, Inc. reported in an 8-K filed July 10, 2024 that June Lee was appointed Class I Director, effective July 10, 2024. Eledon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Tenaya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eledon Pharmaceuticals, Inc. includes David-Alexandre "DA" C. Gros, M.D. (CEO and Board Member), David-Alexandre C. Gros (CEO and Board Member), David-Alexandre C. Gros, M.D. (CEO and Board Member) and 7 others.

“The stockholders of the Company elected Steven Perrin, Ph.D. and June Lee, M.D. as Class I Directors for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027 and until each of their successors has been duly elected and qualified, or until their earlier death, resignation or removal.”
Eledon Pharmaceuticals, Inc. Form 8-K, filed July 10, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Eledon Pharmaceuticals, Inc.

Leadership on record at Tenaya Therapeutics, Inc.

Recent activity